Physician

Jingya Wang, M.D.

According to 2025 Medicare claims, Jingya Wang, M.D. (NPI: 1174765192) practices radiation oncology in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70809-3482.

Wang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 650 traditional Medicare patients, billed 29,988 HCPCS/CPT codes, and received $1,243,721 in Medicare payments. The top billing code was 78815 (Nuclear medicine study from skull base to mid-thigh with ct scan). Part D data shows 416 prescription claims across 156 beneficiaries totaling $6,373 in drug costs, led by Sucralfate (Sucralfate). DME data shows 25 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $91,827 to $1,243,721. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,511 to $6,373. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	111	1,143	$91,827
2016	335	5,893	$411,751
2017	383	10,269	$636,854
2018	409	13,447	$718,176
2019	371	13,887	$686,281
2020	374	10,563	$645,349
2021	339	10,212	$549,615
2022	507	21,321	$965,036
2023	567	32,961	$893,551
2024	650	29,988	$1,243,721

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	49	$2,511
2016	48	100	$3,184
2017	57	178	$5,199
2018	76	239	$5,900
2019	85	252	$6,658
2020	107	333	$8,557
2021	109	269	$4,731
2022	129	334	$6,744
2023	154	421	$10,739
2024	156	416	$6,373

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	25	$2,895
2022	N/R	28	$3,042
2023	N/R	31	$3,750
2024	N/R	25	$5,776

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78815	Nuclear medicine study from skull base to mid-thigh with ct scan	165	214	$1,040
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	176	1,098	$242
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	150	198	$94
77014	Ct guidance for insertion of radiation therapy fields	197	1,158	$84
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	148	18,331	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sucralfate	Sucralfate	12	137	$1,391
Pentoxifylline	Pentoxifylline	17	612	$1,072
Lidocaine Hcl Viscous	Lidocaine Hcl	59	568	$786
Oxycodone Hcl	Oxycodone Hcl	37	453	$329
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	120	$264

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4154	Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$4,644
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	14	$1,132

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Jingya Wang, M.D.?

Tedicare shows public-source Medicare data for Jingya Wang, M.D. (NPI 1174765192), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jingya Wang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jingya Wang, M.D.?

Jingya Wang, M.D. is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does Jingya Wang, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.